Literature DB >> 25667442

In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line.

Musiliyu A Musa1, Moise Y Joseph2, Lekan M Latinwo2, Veera Badisa2, John S Cooperwood3.   

Abstract

UNLABELLED: Coumarins are naturally-occurring compounds with diverse and interesting biological activities. In the present study, we evaluated the in vitro cytotoxic effect of 8-(acetyloxy)-3-[4-(acetyloxy)phenyl]-2-oxo-2H-chromen-7-yl acetate (6); 8-(acetyloxy)-3-(4-methanesulfonyl phenyl)-2-oxo-2H-chromen-7-yl acetate (7); 4-(2-oxo-2H-chromen-3-yl)phenyl acetate (8); 3-(4-methanesulfonylphenyl)-2H-chromen-2-one (9); 4-(4-methyl-2-oxo-2H-chromen-3-yl)phenyl acetate (10); 3-(4-methanesulfonylphenyl)-4-methyl-2H-chromen-2-one (11); 8-(acetyloxy)-3-[4-(acetyloxy)phenyl]-4-methyl-2-oxo-2H-chromen-7-yl acetate (12); and 5-(acetyloxy)-3-[4-(acetyloxy) phenyl]-2-oxo-2H-chromen-7-yl acetate (13) in human lung (A549) cancer and normal lung (MRC-9) cell lines at different concentrations for 48 h using crystal violet dye binding assay. The cytotoxic effect of these coumarin derivatives were compared to the standard drug, docetaxel. Furthermore, the effect of the most active compound on the cell-cycle using propidium iodide, mitochondrial membrane potential (MMP) using tetramethyl rhodamine methyl ester (rhodamine-123) and reactive oxygen species (ROS) production using 2',7'-dichlorofluorescin diacetate (PCFDA) were also evaluated.
RESULTS: Compound 7: had the greatest cytotoxic effect (cytotoxic concentration, CC50=24 μM) and selectivity (MRC-9; CC50>100 μM; inactive) in the A549 cell line, and caused cells to arrest in the S phase of the cell cycle, loss of MMP and increased ROS production in a concentration-dependent manner.
CONCLUSION: These findings suggest that compound 7: could serve as a new lead for the development of novel synthetic compounds with enhanced anticancer activity. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  3-Arylcoumarin derivatives; cell cycle phase; cytotoxic effect; mitochondrial transmembrane potential; reactive oxygen species production

Mesh:

Substances:

Year:  2015        PMID: 25667442      PMCID: PMC4765731     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  29 in total

1.  Novel hydrophilic taxane analogues inhibit growth of cancer cells.

Authors:  Nilufer Jasmine Selimah Fauzee; Ya-Lan Wang; Zhi Dong; Qian-Ge Li; Tao Wang; Muhammad Tasleem Mandarry; Xu Lu; Pan Juan
Journal:  Asian Pac J Cancer Prev       Date:  2012

2.  Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.

Authors:  Musiliyu A Musa; Veera L D Badisa; Lekan M Latinwo; John Cooperwood; Andre Sinclair; Ahkinyala Abdullah
Journal:  Anticancer Res       Date:  2011-06       Impact factor: 2.480

3.  Scanning microspectrofluorometry of rhodamine 123 in multidrug-resistant cells.

Authors:  J M Millot; S Sharonov; M Manfait
Journal:  Cytometry       Date:  1994-09-01

4.  In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines.

Authors:  Musiliyu A Musa; Veera L D Badisa; Lekan M Latinwo; Caroline Waryoba; Ngozi Ugochukwu
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

5.  Synthesis and antiinflammatory activity of coumarin derivatives.

Authors:  Christos A Kontogiorgis; Dimitra J Hadjipavlou-Litina
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

Review 6.  Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer.

Authors:  Aoife Lacy; Richard O'Kennedy
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity.

Authors:  K Shyam; R T Hrubiec; R Furubayashi; L A Cosby; A C Sartorelli
Journal:  J Med Chem       Date:  1987-11       Impact factor: 7.446

8.  Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.

Authors:  Kevin M Foote; Kevin Blades; Anna Cronin; Shaun Fillery; Sylvie S Guichard; Lorraine Hassall; Ian Hickson; Xavier Jacq; Philip J Jewsbury; Thomas M McGuire; J Willem M Nissink; Rajesh Odedra; Ken Page; Paula Perkins; Abid Suleman; Kin Tam; Pia Thommes; Rebecca Broadhurst; Christine Wood
Journal:  J Med Chem       Date:  2013-03-01       Impact factor: 7.446

9.  Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway.

Authors:  Anita Goel; Ashok K Prasad; Virinder S Parmar; Balaram Ghosh; Neeru Saini
Journal:  Chem Biol Interact       Date:  2008-11-18       Impact factor: 5.192

10.  Cytotoxic activity of N, N'-Bis (2-hydroxybenzyl) ethylenediamine derivatives in human cancer cell lines.

Authors:  Musiliyu A Musa; Veera L D Badisa; Lekan M Latinwo
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

View more
  3 in total

1.  Cytotoxic and apoptosis-inducing effects of novel 8-amido isocoumarin derivatives against breast cancer cells.

Authors:  Vishal Das; Partha Pratim Kaishap; Gauri Duarah; Channakeshavaiah Chikkaputtaiah; Hari Prasanna Deka Boruah; Mintu Pal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-02       Impact factor: 3.000

Review 2.  Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.

Authors:  Qiang Zhang; Yu-Hang Miao; Teng Liu; Yin-Ling Yun; Xiao-Ya Sun; Tao Yang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

3.  Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial-Mesenchymal Transition and Migration in A549 Cells.

Authors:  Rodrigo Santos Aquino de Araújo; Julianderson de Oliveira Dos Santos Carmo; Simone Lara de Omena Silva; Camila Radelley Azevedo Costa da Silva; Tayhana Priscila Medeiros Souza; Natália Barbosa de Mélo; Jean-Jacques Bourguignon; Martine Schmitt; Thiago Mendonça de Aquino; Renato Santos Rodarte; Ricardo Olímpio de Moura; José Maria Barbosa Filho; Emiliano Barreto; Francisco Jaime Bezerra Mendonça-Junior
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.